Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

26.27
Delayed Data
As of Dec 02
 -0.02 / -0.08%
Today’s Change
24.47
Today|||52-Week Range
41.91
-30.48%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close26.29
Today’s open26.29
Day’s range25.96 - 26.80
Volume282,484
Average volume (3 months)486,470
Market cap$1.1B
Dividend yield--
Data as of 4:02pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)-75.71%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+16.14%
P/E ratio26.8
Price/Sales3.62
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.14+0.45%
SUPNSupernus Pharmaceuti...+0.65+3.07%
DERMDermira Inc+0.70+2.31%
PTLAPortola Pharmaceutic...+0.62+3.58%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
EVP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts


Search for Jobs